MedTrace Logo

Urinary Catheter Self-Discontinuation After Urogynecology Surgery

NCT05860634 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 118

Last updated 2024-12-11

No results posted yet for this study

Summary

The goal of this randomized clinical trial is to determine if removal of transurethral urinary catheters by patients at home is as safe as catheter removal in the office following urogynecologic surgery.

Participants will be randomized to either standard catheter removal in the office or catheter self-removal at home.

Conditions

  • Urinary Retention
  • Pelvic Organ Prolapse
  • Stress Urinary Incontinence
  • Catheter Related Complication

Interventions

PROCEDURE

Catheter self-discontinuation

Self-discontinuation of a transurethral catheter

Sponsors & Collaborators

  • University of Texas at Austin

    lead OTHER

Principal Investigators

  • Mary M Rieger, MD · University of Texas at Austin

  • Collin M McKenzie, MD · University of Texas at Austin

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2025-10-01
Completion
2025-11-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05860634 on ClinicalTrials.gov